http://www.reportbuyer.com/rss.htmlSearch our catalogue of comprehensive market intelligence reports on Osteoporosis.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/diseases/osteoporosis/pth_receptor_agonists.htmlProduct description The present Competitive Intelligence Report about Parathyroid Hormone (PTH) Receptor Agonists or PTH Analogs provides a competitor evaluation in the field of R&D projects with analogs of PTH used to stimulate the PTH receptor for the treatment of osteoporosis or other bone-related diseases as of January 2009. PTH analogs are recombinant and synthetic peptides delivered by injection, inhalation, nasal, oral and transdermal administration. The report includes a compilation of current active projects in research and development of PTH receptor agonists. b8fb162176e2cea9dd559d4084657c15Thu, 01 Jan 2009 12:00:00 GBDiseases/Osteoporosishttp://www.reportbuyer.com/pharma_healthcare/diseases/osteoporosis/u_s_osteoporosis_market.htmlThis research service covers the U. S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. 562ba41440a4109d3b6aa57647872f4fFri, 06 Jun 2008 12:00:00 GBDiseases/Osteoporosishttp://www.reportbuyer.com/pharma_healthcare/diseases/osteoporosis/osteoporosis_therapeutics.htmlThis report analyzes the worldwide markets for Osteoporosis Therapeutics in Millions of US$. The specific product segments analyzed are Bisphosphonates, ERT Drugs, SERMs, and Calcitonins. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. bfd17433a1447e3857aaf18b67367988Mon, 03 Mar 2008 12:00:00 GBDiseases/Osteoporosis